[Research progress on pseudocirrhosis]

  • 0Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.

Summary

This summary is machine-generated.

Pseudocirrhosis, a condition in liver metastasis patients, presents with portal hypertension symptoms and unique imaging findings. This review explores its prevalence, causes, diagnosis, and impact on survival.

Area Of Science

  • Hepatology
  • Oncology
  • Pathology

Background

  • Pseudocirrhosis frequently complicates liver metastases from malignant tumors, mimicking liver cirrhosis.
  • It manifests with portal hypertension symptoms (edema, ascites, bleeding) and characteristic imaging findings like nodules and caudate lobe enlargement.
  • Histological features include diffuse tumor infiltration, fibrosis, vascular thrombosis, and pseudolobule formation.

Approach

  • This review synthesizes current research from case reports, observational studies, and meta-analyses.
  • It examines the prevalence, etiology, pathogenesis, diagnostic challenges, treatment strategies, and prognostic implications of pseudocirrhosis.
  • The review aims to clarify the unclear relationships between pseudocirrhosis onset, tumor characteristics, and chemotherapy use.

Key Points

  • Pathogenesis involves tumor cell infiltration and potential chemotherapy-induced toxicity.
  • Atypical clinical and imaging features pose diagnostic challenges for clinicians.
  • Pseudocirrhosis negatively impacts patient survival by shortening the median survival time.

Conclusions

  • Pseudocirrhosis represents a significant challenge in managing patients with malignant tumors and liver metastases.
  • Further research is needed to elucidate the precise factors influencing its development and to optimize patient outcomes.
  • Understanding pseudocirrhosis is crucial for improving diagnosis, treatment, and prognosis in affected individuals.